Strategies Wealth Advisors’s Zomedica Corp. ZOM Stock Holding History

Strategies Wealth Advisors’s Portfolio ZOM Stock Details ZOM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-12,500	Closed	-$2.09K	–	91
2023 Q3	$2.09K	Hold	12,500	–	–	﹤0.01%	78
2023 Q2	$2.5K	Hold	12,500	–	–	﹤0.01%	84
2023 Q1	$2.65K	Hold	12,500	–	–	﹤0.01%	78
2022 Q4	$2.04K	Buy	+12,500	New	+$2.56K	﹤0.01%	77
2022 Q2	$2.75K	Hold	12,500	–	–	﹤0.01%	84
2022 Q1	$4.21K	Hold	12,500	–	–	﹤0.01%	82
2021 Q4	$3.83K	Buy	+12,500	New	+$5.63K	﹤0.01%	81

Other funds holding ZOM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ProShare Advisors Bethesda, Maryland $67.5B AUM 28.09% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

CCM

Connective Capital Management Palo Alto, California $121M AUM 39.82% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Strategies Wealth Advisors's ZOM Position: Q4 2023 in Review

Strategies Wealth Advisors sold out of Zomedica Corp. (ZOM) in Q4 2023, closing a stake of 12,500 shares — an estimated $2.09K sold.

Strategies Wealth Advisors first reported a position in ZOM in Q4 2021 and held it in 7 quarters. The position peaked at $4.21K in Q1 2022. 92 funds tracked by Wall St. Rank hold ZOM as of Q4 2023.

Strategies Wealth Advisors reported no remaining Zomedica Corp. position as of Q4 2023 after selling out during the quarter.
Strategies Wealth Advisors sold 12,500 Zomedica Corp. shares in Q4 2023, an estimated $2.09K.
Strategies Wealth Advisors first reported a position in Zomedica Corp. in Q4 2021 and held it in 7 quarters.
Strategies Wealth Advisors's Zomedica Corp. position peaked at $4.21K in Q1 2022.
92 funds tracked by Wall St. Rank held Zomedica Corp. as of Q4 2023.

Based on Strategies Wealth Advisors's 13F filing for Q4 2023, filed 22 Jan 2024.